Tissium
3 known investors
TISSIUM develops biomorphic polymer technology, including proprietary polymers, activation technologies, and delivery devices, to reconstruct damaged tissue and restore its function across multiple therapeutic areas. The company operates an integrated innovation, design, manufacturing, and commercialization platform serving its own programs and co-development partnerships in the medtech industry.
Founders & leadership
Investors · 3
Competitors · 3
by search overlap
Elysium Health Website7 shared keywordsElysium develops healthcare products focused on aging research and healthy aging rather than disease treatment. The company translates aging research into accessible solutions for individuals seeking to improve their long-term health outcomes.
Globus Medical6 shared keywordsGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
Ossium Health5 shared keywordsOssium Health develops cellular therapies and bioengineered products for clinical use, leveraging adult stem cell technologies and advanced cell processing platforms. The company operates as a clinical-stage biotech firm manufacturing and distributing cellular therapeutics for patients with organ and tissue diseases.
Companies competing with Tissium for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Tissium do?
- TISSIUM develops biomorphic polymer technology, including proprietary polymers, activation technologies, and delivery devices, to reconstruct damaged tissue and restore its function across multiple therapeutic areas. The company operates an integrated innovation, design, manufacturing, and commercialization platform serving its own programs and co-development partnerships in the medtech industry.
- Who founded Tissium?
- Tissium was founded by Christophe Bancel, Maria Pereira.
- Who are Tissium's investors?
- Tissium's investors include Cathay Health, Karista, Sofinnova Partners.